SBH
SILK

Segall Bryant & Hamill’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History

Segall Bryant & Hamill’s Portfolio SILK Stock Details SILK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-118,929
Closed -$1.78M – 518
2023
Q3 		$1.78M Sell
118,929
-869
-0.7% -$18.1K 0.02% 414
2023
Q2 		$3.89M Buy
119,798
+663
+0.6% +$24.2K 0.04% 370
2023
Q1 		$4.66M Sell
119,135
-22,077
-16% -$1.08M 0.05% 346
2022
Q4 		$7.46M Sell
141,212
-48,440
-26% -$2.36M 0.08% 263
2022
Q3 		$8.54M Buy
189,652
+3,776
+2% +$162K 0.1% 239
2022
Q2 		$6.76M Buy
185,876
+55,291
+42% +$2.01M 0.08% 264
2022
Q1 		$5.39M Buy
130,585
+306
+0.2% +$10.8K 0.05% 322
2021
Q4 		$5.55M Buy
130,279
+34,430
+36% +$1.72M 0.05% 312
2021
Q3 		$5.28M Buy
95,849
+2,545
+3% +$133K 0.05% 323
2021
Q2 		$4.46M Buy
93,304
+5,566
+6% +$284K 0.04% 345
2021
Q1 		$4.44M Sell
87,738
-1,549
-2% -$86.1K 0.04% 361
2020
Q4 		$5.62M Sell
89,287
-1,657
-2% -$103K 0.06% 274
2020
Q3 		$6.11M Buy
90,944
+65,880
+263% +$3.6M 0.08% 229
2020
Q2 		$1.05M Buy
25,064
+9,604
+62% +$369K 0.02% 429
2020
Q1 		$487K Buy
15,460
+3,788
+32% +$152K 0.01% 595
2019
Q4 		$471K Sell
11,672
-932
-7% -$32.6K 0.01% 662
2019
Q3 		$409K Buy
+12,604
New +$502K 0.01% 686

Other funds holding SILK

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JFG
Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Segall Bryant & Hamill's SILK Position: Q4 2023 in Review

Segall Bryant & Hamill sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q4 2023, closing a stake of 118,929 shares — an estimated $1.78M sold.

Segall Bryant & Hamill first reported a position in SILK in Q3 2019 and held it in 17 quarters. The position peaked at $8.54M in Q3 2022. 133 funds tracked by Wall St. Rank hold SILK as of Q4 2023.

  • Segall Bryant & Hamill reported no remaining Silk Road Medical, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Segall Bryant & Hamill sold 118,929 Silk Road Medical, Inc. Common Stock shares in Q4 2023, an estimated $1.78M.
  • Segall Bryant & Hamill first reported a position in Silk Road Medical, Inc. Common Stock in Q3 2019 and held it in 17 quarters.
  • Segall Bryant & Hamill's Silk Road Medical, Inc. Common Stock position peaked at $8.54M in Q3 2022.
  • 133 funds tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q4 2023.

Based on Segall Bryant & Hamill's 13F filing for Q4 2023, filed 14 Feb 2024.